WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 4'0001 Infant (under 12 months) mortality rate: 122
GDP / capita (US$): 9'6471 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 2'930  2'925  2'917  2'906  2'894  3'070  3'538  3'100 
Births 38  39  40  41  42  40  75  74 
Surviving infants 38  39  40  41  41  38  71  70 
Pop. less than 5 years 198  202  206  207  208  197  386  327 
Pop. less than 15 years 586  583  579  573  566  792  1'063  938 
Female 15-49 years 758  763  770  777  786  863  905  842 

Number of reported cases

(Click for retrospective incidence data for Armenia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  33  13  10  15  879 
Mumps
ChartChart
  3'431 
Pertussis
ChartChart
  77  15  27  85  30  10  469 
Polio*
ChartChart
 
Rubella
ChartChart
  673 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Armenia)
Vaccine year result method % card seen                                                
BCG 2014  99  DHS   96  99  99  99  99  99  97 
DTP1 2014  99  DHS   96  97  97  97  97  97 
DTP3 2014  93  DHS   96  94  94  94  93  95  93 
DTP4          93  98  94  93 
IPV1          92  34 
HepB_BD          97  98  98  98  98  97 
HepB3 2014  93  DHS   96  94  94  94  93  95  55 
Hib3 2014  93  DHS   96  94  94  94  93  95 
JapEnc         
MCV1          96  97  97  97  97  92 
MCV2          97  97  97  97  97  94 
MenA          22 
PCV1          97  97  45 
PCV2          98 
PCV3 2014  52  DHS   96  94  94  44 
Pol3 2014  93  DHS   96  96  96  96  95  96  96 
Rota1          96  95  95  94  92 
RotaC 2014  90  DHS   96  94  94  93  91  90 
RCV1          96  97  97  97  97 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Armenia)
BCG
ChartChart
  99  99  99  99  99  97 
DTP1
ChartChart
  97  97  97  97  97  97 
DTP3
ChartChart
  94  94  94  93  95  93 
HepB3
ChartChart
  94  94  94  93  95  55 
HepB_BD
ChartChart
  97  98  98  98  98  97 
Hib3
ChartChart
  94  94  94  93  95 
IPV1
ChartChart
  92  34 
MCV1
ChartChart
  96  97  97  97  97  92 
MCV2
ChartChart
  97  97  97  97  97  94 
PCV3
ChartChart
  94  94  44 
Pol3
  96  96  96  95  96  96 
RCV1
ChartChart
  96  97  97  97  97 
RotaC
ChartChart
  94  94  93  91  33 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 48  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 88
From 80 to 89% 13
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 12, 18 weeks; 18 months; Yes
HepA_Adult 16, 17 years; Yes only young men
HepB_Adult Yes risk groups
HepB_Pediatric birth; Yes
HPV 13 years; Yes from December 2017; females only
Influenza_Adult Yes adults with chronic illness, pregnant women, health care workers, residents living in long-term care facilities, other risk groups
Influenza_Pediatric Yes children with chronic illness
IPV 24 weeks; Yes
MenACWY-135 conj 16-17 years; Yes young men
MMR 1, 6, 16-17 years; Yes dose at y16-y17 given only to young men not having received the 2nd dose
OPV 6, 12, 18 weeks; 18 months; 6 years; Yes
Pneumo_conj 6, 12, 18 weeks; 16-17 years; Yes 4th dose only for young men
Rabies Yes risk groups
Rotavirus 6, 12 weeks; Yes
Td 6, 15-16, 26-30, 36-40, 46-50, 56-60 years; Yes
Tularemia 16-17 years; Yes young men

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2016-2020  2010-2015  2010-2015  2010-2015  2010-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 48  48  48        51 

System performance

Total Nº districts in country number 48  48  48  51  51  51  51 
Nº districts with DTP3 coverage >=80% number 48  43  48  51  51  51  51 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  90  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 41  45  42  44  47  47  48 
% of districts with MCV1 coverage >=95% From 0 to 100% 85  94  88  86  92  92  94 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 106  60  90  99    65  75 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.